- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03183336
Horizontal Ridge Augmentation of the Mandible Autogenous Block Grafts
July 6, 2017 updated by: Ahmed H Osman, Cairo University
Horizontal Ridge Augmentation of the Mandible Using Interpositional Autogenous Block Grafts Versus Onlay Block Grafts; Randomized Controlled Clinical Trial
20 subjects presenting with horizontal mandibular ridge width less than 5 mm were selected and randomly divided two groups (10 in each group).
the first group received interpositional block grafts (harvested from the chin and ramus) covered with Platelet-rich fibrin membrane.
the second group received onlay block grafts (harvested from the chin and ramus) and covered with Platelet-rich fibrin membrane.
the grafts are left for 4 months.
the alveolar ridge width dimensions is then measured using radiographic analysis using cone-beam computed tomography scans
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
20
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients of both sexes with a minimum vertical bone height above the inferior alveolar canal of 10mm in the edentulous region.
Patients should have ridge thickness less than 5mm measured 2mm from the alveolar crest Patients should be free from any systemic disease that may affect normal healing of bone, and predictable outcome.
Exclusion Criteria:
- Patients with any systemic disease that may affect normal bone healing. Patients with drug allergies, drug or alcohol abuse, periodontal diseases or poor oral hygiene
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Interpositional block graft
ridge split interpositional block graft
|
|
|
Active Comparator: Onlay block graft
decortication onlay block graft
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
alveolar ridge width gained
Time Frame: 4 months
|
radiographic analysis following ridge augmentation using Cone beam computed tomography
|
4 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
patient morbidity following the surgical procedure
Time Frame: 14 days
|
pain value on pain scale
|
14 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 1, 2016
Primary Completion (Anticipated)
August 1, 2017
Study Completion (Anticipated)
September 1, 2017
Study Registration Dates
First Submitted
June 6, 2017
First Submitted That Met QC Criteria
June 8, 2017
First Posted (Actual)
June 12, 2017
Study Record Updates
Last Update Posted (Actual)
July 11, 2017
Last Update Submitted That Met QC Criteria
July 6, 2017
Last Verified
July 1, 2017
More Information
Terms related to this study
Other Study ID Numbers
- cebc.cairou
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Horizontal Ridge Deficiency
-
University of MichiganWithdrawnHorizontal Ridge Deficiency | Vertical Ridge DeficiencyUnited States
-
Cairo UniversityNot yet recruitingHorizontal Ridge Deficiency | Horizontal Bone AugmentationEgypt
-
Mansoura UniversityCompleted
-
Ain Shams UniversityCompletedHorizontal Ridge DeficiencyEgypt
-
University of MichiganRecruiting
-
Cairo UniversityRecruiting
-
Cairo UniversityCompletedHorizontal Ridge DeficiencyEgypt
-
University of BaghdadCompleted
-
Saint-Joseph UniversityCompletedHorizontal Ridge DeficiencyLebanon
-
Cairo UniversityNot yet recruitingHorizontal Ridge Deficiency
Clinical Trials on ridge split interpositional block graft
-
Cairo UniversityNot yet recruiting
-
Ain Shams UniversityCompletedHorizontal Atrophy of Edentulous Alveolar RidgeEgypt
-
Cairo UniversityNot yet recruiting
-
Cairo UniversityNot yet recruitingAtrophic Maxilla | Vertical Ridge DeficiencyEgypt
-
Cairo UniversityCompleted
-
University of TriesteInternational Piezosurgery AcademyCompletedBone Atrophy, Alveolar
-
Mansoura UniversityCompletedAlveolar Ridge AugmentationEgypt
-
Markman Biologics CorporationUnknown
-
Cairo UniversityNot yet recruitingAlveolar Bone LossEgypt
-
University Hospital, GhentDutch Burnwound Foundation, NetherlandCompletedFull Thickness Skin DefectsBelgium